These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36118247)

  • 1. Advances in multi-omics research on viral hepatitis.
    Xiang Z; Li J; Lu D; Wei X; Xu X
    Front Microbiol; 2022; 13():987324. PubMed ID: 36118247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in viral hepatitis: advances and review.
    Yang J; Wang D; Li Y; Wang H; Hu Q; Wang Y
    Front Cell Infect Microbiol; 2023; 13():1189417. PubMed ID: 37265499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention.
    Lanini S; Ustianowski A; Pisapia R; Zumla A; Ippolito G
    Infect Dis Clin North Am; 2019 Dec; 33(4):1045-1062. PubMed ID: 31668190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: a hospital based study.
    Jain P; Prakash S; Gupta S; Singh KP; Shrivastava S; Singh DD; Singh J; Jain A
    Indian J Med Microbiol; 2013; 31(3):261-5. PubMed ID: 23883712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma.
    Cui D; Li W; Jiang D; Wu J; Xie J; Wu Y
    Front Med (Lausanne); 2021; 8():754709. PubMed ID: 34660653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Risk Factors for Acute Viral Hepatitis in Bangladesh: An Overview.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.
    Makiala-Mandanda S; Le Gal F; Ngwaka-Matsung N; Ahuka-Mundeke S; Onanga R; Bivigou-Mboumba B; Pukuta-Simbu E; Gerber A; Abbate JL; Mwamba D; Berthet N; Leroy EM; Muyembe-Tamfum JJ; Becquart P
    J Clin Microbiol; 2017 May; 55(5):1299-1312. PubMed ID: 28202798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study.
    Hassan-Kadle MA; Osman MS; Ogurtsov PP
    World J Gastroenterol; 2018 Sep; 24(34):3927-3957. PubMed ID: 30228786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can we foresee the end of the alphabet in viral hepatitis?].
    Ehrmann J; Krc I
    Vnitr Lek; 2000 Apr; 46(4):232-4. PubMed ID: 11227176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and analysis of HAV-HEV, HGV infection in patients with viral hepatitis].
    Xiong LS; Cui SF; Zhou JG; Xing Y
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):395-6. PubMed ID: 15268800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEROPREVALENCE OF HAV, HBV, HCV, AND HEV AMONG ACUTE HEPATITIS PATIENTS AT KENYATTA NATIONAL HOSPITAL IN NAIROBI, KENYA.
    Muchiri I; Okoth FA; Ngaira J; Tuei S
    East Afr Med J; 2012 Jun; 89(6):199-205. PubMed ID: 26856042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran.
    Behzadi MA; Leyva-Grado VH; Namayandeh M; Ziyaeyan A; Feyznezhad R; Dorzaban H; Jamalidoust M; Ziyaeyan M
    BMC Infect Dis; 2019 Dec; 19(1):1027. PubMed ID: 31795979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults.
    Gupta E; Ballani N; Kumar M; Sarin SK
    Indian J Gastroenterol; 2015 Nov; 34(6):448-52. PubMed ID: 26589230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Testing for Hepatitis Viruses: A Growing Need.
    Pauly MD; Ganova-Raeva L
    Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.
    Cabezas C; Trujillo O; Gonzales-Vivanco Á; Benites Villafane CM; Balbuena J; Borda-Olivas AO; Suarez-Jara MA; Peceros FM; Ramírez-Soto MC
    PLoS One; 2020; 15(6):e0234273. PubMed ID: 32542052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multi-omics approach to investigate the etiology of non-communicable diseases: recent advance and applications].
    Pang YJ; Lyu J; Yu CQ; Sun DJY; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):1-9. PubMed ID: 33503692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17.
    Talaat M; Afifi S; Reaves EJ; Abu Elsood H; El-Gohary A; Refaey S; Hammad R; Abdel Fadeel M; Kandeel A
    BMC Infect Dis; 2019 Feb; 19(1):159. PubMed ID: 30764780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel single-step multiplex real-time polymerase chain reaction assay for simultaneous quantification of hepatitis virus A, B, C, and E in serum.
    Irshad M; Ansari MA; Irshad K; Lingaiah R
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1869-76. PubMed ID: 23800094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.